MedTrace Logo

Ablation of Renal Masses Outcomes Registry (ARMOR): Ablation Procedure and Quality of Life Assessment

NCT01888198 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 294

Last updated 2025-07-25

No results posted yet for this study

Summary

The purpose of this study is to better understand how effective ablation is for destroying tumor cells in the kidney and whether quality of life is improved for patients. Participation in ARMOR may involve retrospective data collection only, combined retrospective and prospective data collection, or prospective data collection

Conditions

  • Renal Cancer

Interventions

BEHAVIORAL

(EORTC QLQ-C30) questionnaire

BEHAVIORAL

EuroQol EQ-5D 7-item questionnaire

Sponsors & Collaborators

Principal Investigators

  • Fourat Ridouani, MD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2026-06-30
Completion
2026-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01888198 on ClinicalTrials.gov